Chronic Obstructive Pulmonary Disease References

Last updated: 25 June 2024
  1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995 Nov;152(5)(Pt 2):S77-S121. PMID: 7582322
  2. The Asia Pacific COPD Roundtable Group. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology. 2005 Jan;10(1):009-17. PMID: 15691232
  3. Ambrosino N, Vagheggini G. Non-invasive ventilation in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2007 Dec;2(4):471-476. PMID: 18268921
  4. Blanchard AR. Treatment of COPD exacerbations: pharmacologic options and modification of risk factors. Postgrad Med. 2002 Jun;111(6):65-75. PMID: 12082921
  5. Decramer M, Celli B, Kesten S, et al; UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009 Oct;374(9696):1171-1178. PMID: 19716598
  6. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health study. Chest. 2009 Dec;136(6):1456-1465. doi: 10.1378/chest.08-3016. PMID: 19581353
  7. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [full version of NICE guideline No.12]. Thorax. 2004 Feb;59(Suppl 1):001-232. PMID: 15041752
  8. Doherty DE. Early detection and management of COPD: what you can do to reduce the impact of this disabling disease. Postgrad Med. 2002 Jun;111(6):41-4, 49-50, 53 passim. PMID: 12082920
  9. Gross N, Levin D. Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of disease. Am J Med. 2008 Jul;121(7)(Suppl):S13-S24. PMID: 18558103
  10. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J. 2007 Sep;14(Suppl B):5B-32B. doi: 10.1155/2007/830570. PMID: 17885691
  11. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008 Jan;15(Suppl Suppl A):1A-8A. doi: 10.1155/2008/641965. PMID: 18292855
  12. Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 Oct;359(15):1543-1554. PMID: 18836213
  13. Qaseem A, Snow V, Shekelle P, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007 Nov;147(9):633-638. PMID: 17975186
  14. Rennard SI. Overview of causes of COPD. New understanding of pathogenesis and mechanisms can guide future therapy. Postgrad Med. 2002 Jun;111(6):28-38. PMID: 12082919
  15. Snow V, Lascher S, Mottur-Pilson C; Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001 Apr;134(7):595-599. PMID: 11281744
  16. Yassin HM, Dever LL. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections. Expert Opin Investig Drugs. 2001 Feb;10(2):353-367. PMID: 11178347
  17. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  18. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. http://guidance.nice.org.uk/. 2010.
  19. Global Initiative for Chronic Obstructive Lung Disease. At-A-Glance outpatient management reference for chronic obstructive disease (COPD). Based on the global strategy for diagnosis, management and prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) revised 2011. http://www.goldcopd.org/. Jan 2012.
  20. Ministry of Health Singapore. Clinical practice guidelines: chronic obstructive pulmonary disease. MOH (Singapore). http://www.moh.gov.sg. 2006
  21. National Heart, Lung and Blood institute. Global Initiative for Asthma. Global strategy for asthma management and prevention. http://www.ginasthma.org/. 2006. Accessed 07 Sep 2007.
  22. National Heart, Lung, and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention Updated 2009. GINA. http://www.ginasthma.org. 2009.
  23. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. NICE. http://www.nice.org.uk. 2004.
  24. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/. 2011.
  25. Alberta Medical Association. Guideline for the management of acute exacerbations of chronic bronchitis (AECB)/acute or chronic COPD. Alberta Medical Association. http://www.albertadoctors.org/. May 2000. Accessed 05 Aug 2002.
  26. Institute for Clinical Systems Improvement (ICSI). Health care guideline: chronic obstructive pulmonary disease. http://www.icsi.org. 2004
  27. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd.org/. 2014. Accessed 15 Apr 2015.
  28. Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. Updated 2014. http://www.goldcopd.org/. 2014. Accessed 15 Apr 2015.
  29. Qaseem A, Wilt TJ, Weinberger SE et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug;155(3):179-191. doi: 10.7326/0003-4819-155-3-201108020-00008. PMID: 21810710
  30. American Thoracic Society. COPD assessment test (CAT). American Thoracic Society website. http://www.thoracic.org/. 2014.
  31. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. GOLD website. http://www.goldcopd.org/. 2015. Accessed 30 Apr 2015.
  32. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 report. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://goldcopd.org/. 2017.
  33. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (2018 update). GINA. http://www.ginasthma.org. 2018. Accessed 21 Feb 2019.
  34. Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 Mar;49(3). doi: 10.1183/13993003.00791-2016. Accessed 5 Nov 2018. PMID: 28298398
  35. Ferguson GT, Make B. Management of stable chronic obstructive pulmonary disease. UptoDate. http://www.uptodate.com/. Jan 2019.
  36. Agency for Care Effectiveness (ACE), Ministry of Health Singapore. Appropriate care guide: Diagnosing chronic obstructive pulmonary disease: A systematic approach. Agency for Care Effectiveness (ACE). http://www.ace-hta.gov.sg/. Nov 2018.
  37. Agency for Care Effectiveness (ACE), Ministry of Health Singapore. Appropriate care guide: Managing stable chronic obstructive pulmonary disease: Focusing on inhalers. Agency for Care Effectiveness (ACE). http://www.ace-hta.gov.sg/. Sep 2018.
  38. Agency for Care Effectiveness (ACE), Ministry of Health Singapore. Long-acting muscarinic antagonist (LAMA) monotherapy and combination therapy with long-acting beta2 agonists (LAMA/LABA) for the treatment of chronic obstructive pulmonary disease: Technology Guidance from the MOH Drug Advisory Committee. Agency for Care Effectiveness (ACE). http://www.ace-hta.gov.sg/. Jul 2018.
  39. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2019 report. GOLD. http://goldcopd.org/. 2019.
  40. Guidelines and Protocols Advisory Committee, British Columbia Medical Association (BCMA). Chronic obstructive pulmonary disease (COPD): Diagnosis and management. British Columbia Ministry of Health. https://www2.gov.bc.ca/. Feb 2017.
  41. Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J. 2017 Nov;50(5). doi: 10.1183/13993003.00610-2017. Accessed 21 Feb 2019. PMID: 29191952
  42. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing. NICE. https://www.nice.org.uk/. Dec 2018.
  43. National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE. https://www.nice.org.uk/. Dec 2018.
  44. Stoller JK. Management of exacerbations of chronic obstructive pulmonary disease. UpToDate. http://www.uptodate.com/. Jan 2019.
  45. Wedzicha JA, Calverley PMA, Albert RK, et al. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 Sep;50(3). doi: 10.1183/13993003.02265-2016. PMID: 28889106
  46. Celli BR. Pulmonary rehabilitation. UpToDate. https://www.uptodate.com. 12 Jul 2018.
  47. Ferguson GT, Make B. Stable COPD: Follow-up pharmacologic management. UpToDate. https://www.uptodate.com. 31 Oct 2019.
  48. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2020 report. GOLD. https://goldcopd.org. 2020.
  49. Bourbeau J, Bhutani M, Hernandez P, et al. Canadian Thoracic Society clinical practice guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2019 Oct;3(4):210-232. doi: 10.1080/24745332.2019.1668652.
  50. Ergan B, Oczkowski S, Rochwerg B, et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Reps J. 2019 Sep;54(3):1901003. doi: 10.1183/13993003.01003-2019. PMID: 31467119
  51. Ferguson GT, Make B. Management of refractory chronic obstructive pulmonary disease. UpToDate. https://www.uptodate.com. 11 Jun 2020.
  52. Ferguson GT, Make B. Stable COPD: initial pharmacologic management. UpToDate. https://www.uptodate.com. 17 Dec 2021.
  53. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 report. GOLD. http://www.goldcopd.org. 2021.
  54. Macrea M, Oczkowski S, Rochwerg B, et al. Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020 Aug;202(4):e74-e87. doi: 10.1164/rccm.202006-2382ST. PMID: 32795139
  55. Stoller JK. COPD exacerbations: management. UpToDate. https://www.uptodate.com. 30 Nov 2020.
  56. Limpoco AG, Palma-Mendoza NRN, Sta. Ana J. Effectiveness of health education interventions directed to patient, family, community on chronic obstructive pulmonary disease in family and community practice: a meta-analysis. The Filipino Family Physician. 2021;59(1):2-18.
  57. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2022 report. GOLD. http://www.goldcopd.org. 2021.
  58. Philippine College of Chest Physicians Council on COPD and Pulmonary Rehabilitation, 2018-2021. 2021 Summary of consensus statements on the diagnosis and management of chronic obstructive pulmonary disease (COPD) in the Philippines. PCCP. https://philchest.org/. 2021.
  59. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2023 report. GOLD. http://www.goldcopd.org/. 2023.
  60. Stoller JK. COPD exacerbations: management. UpToDate. https://www.uptodate.com/. 30 Dec 2022.
  61. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. GOLD. http://www.goldcopd.org/. 2024.